Patient care & support

JCVI issues advice on vaccinating children and young people

The Joint Committee on Vaccination and Immunisation (JCVI) is now advising that children at increased risk of serious COVID-19 disease should be offered the Pfizer-BioNTech vaccine.

This includes children aged 12 to 15 with severe neurodisabilities, Down’s syndrome, immunosuppression, and multiple or severe learning disabilities.

While children with Duchenne muscular dystrophy (DMD) are not explicitly mentioned,  this announcement means that some 12 to 15 years olds with DMD may now be eligible for vaccination due to being immunosuppressed. Duchenne UK is awaiting expert advice and guidance on this and will update the community as soon as we can.

The JCVI is also recommending that children and young people aged 12 to 17 who live with an immunosuppressed person should be offered the vaccine, in order to indirectly protect their immunosuppressed household contacts. Under existing advice, children aged 16 to 17 with underlying health conditions are already eligible for the vaccination.

You can read the full announcement from the JCVI on the Government’s website, and for more in-depth information on the vaccination programme please consult the Green Book.

Published on 21 July 2021

Share this article
Categories Patient care & support Policy and campaigning